Inhibition of MAP kinase/NF-kB mediated signaling and attenuation of lipopolysaccharide induced severe sepsis by cerium oxide nanoparticles.

[1]  Ravikumar Arvapalli,et al.  Cerium oxide nanoparticles inhibit lipopolysaccharide induced MAP kinase/NF-kB mediated severe sepsis , 2015, Data in brief.

[2]  Ravikumar Arvapalli,et al.  Lipopolysaccharide induced MAP kinase activation in RAW 264.7 cells attenuated by cerium oxide nanoparticles , 2015, Data in brief.

[3]  D. Butterfield,et al.  Persistent Hepatic Structural Alterations Following Nanoceria Vascular Infusion in the Rat , 2014, Toxicologic pathology.

[4]  Dawei Wang,et al.  Advances in sepsis-associated liver dysfunction , 2014, Burns & Trauma.

[5]  S. Seal,et al.  Sustained inhibition of neovascularization in vldlr-/- mice following intravitreal injection of cerium oxide nanoparticles and the role of the ASK1-P38/JNK-NF-κB pathway. , 2014, Biomaterials.

[6]  Lijuan Chen,et al.  Nanoceria inhibit expression of genes associated with inflammation and angiogenesis in the retina of Vldlr null mice. , 2013, Experimental eye research.

[7]  Kang Yang,et al.  A New Method to Isolate and Culture Rat Kupffer Cells , 2013, PloS one.

[8]  Hak-Ju Kim,et al.  Anti-inflammatory Effect of Oyster Shell Extract in LPS-stimulated Raw 264.7 Cells , 2013, Preventive nutrition and food science.

[9]  Sudipta Seal,et al.  Bio‐distribution and in vivo antioxidant effects of cerium oxide nanoparticles in mice , 2013, Environmental toxicology.

[10]  M. Cohenford,et al.  Arsenic trioxide (As(2)O(3)) induces apoptosis and necrosis mediated cell death through mitochondrial membrane potential damage and elevated production of reactive oxygen species in PLHC-1 fish cell line. , 2013, Chemosphere.

[11]  Sun-Mee Lee,et al.  Genipin Attenuates Sepsis by Inhibiting Toll-Like Receptor Signaling , 2012, Molecular medicine.

[12]  I. Rahman.  Edinburgh Research Explorer Pharmacological Antioxidant Strategies as Therapeutic Interventions for Copd Nih Public Access , 2022 .

[13]  Hartmut Jaeschke,et al.  Acetaminophen hepatotoxicity and repair: the role of sterile inflammation and innate immunity , 2012, Liver international : official journal of the International Association for the Study of the Liver.

[14]  Siva K. Nalabotu,et al.  Intratracheal instillation of cerium oxide nanoparticles induces hepatic toxicity in male Sprague-Dawley rats , 2011, International journal of nanomedicine.

[15]  P. Kolattukudy,et al.  Cerium Oxide Nanoparticles Inhibits Oxidative Stress and Nuclear Factor-κB Activation in H9c2 Cardiomyocytes Exposed to Cigarette Smoke Extract , 2011, Journal of Pharmacology and Experimental Therapeutics.

[16]  S. Powers,et al.  Reactive oxygen and nitrogen species as intracellular signals in skeletal muscle , 2011, The Journal of physiology.

[17]  E. Traversa,et al.  Pharmacological potential of cerium oxide nanoparticles. , 2011, Nanoscale.

[18]  M. Garcia-Conesa,et al.  Lack of effect of oral administration of resveratrol in LPS-induced systemic inflammation , 2011, European journal of nutrition.

[19]  A. Casrouge,et al.  Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV. , 2011, The Journal of clinical investigation.

[20]  Sudipta Seal,et al.  Anti-inflammatory properties of cerium oxide nanoparticles. , 2009, Small.

[21]  F. Klamt,et al.  Antioxidant treatment reverses mitochondrial dysfunction in a sepsis animal model. , 2008, Mitochondrion.

[22]  Sudipta Seal,et al.  Protein adsorption and cellular uptake of cerium oxide nanoparticles as a function of zeta potential. , 2007, Biomaterials.

[23]  M. Merx,et al.  Sepsis and the heart. , 2007, Circulation.

[24]  M. Atkinson,et al.  Novel synthesis of cerium oxide nanoparticles for free radical scavenging. , 2007, Nanomedicine.

[25]  M. Yen,et al.  Protective effect of baicalein against endotoxic shock in rats in vivo and in vitro. , 2007, Biochemical pharmacology.

[26]  L. Rogers,et al.  Cardioprotective effects of cerium oxide nanoparticles in a transgenic murine model of cardiomyopathy. , 2007, Cardiovascular research.

[27]  G. Kolios,et al.  Role of Kupffer cells in the pathogenesis of liver disease. , 2006, World journal of gastroenterology.

[28]  M. Granado,et al.  Inactivation of Kupffer cells by gadolinium administration prevents lipopolysaccharide-induced decrease in liver insulin-like growth factor-I and IGF-binding protein-3 gene expression. , 2006, The Journal of endocrinology.

[29]  Dechang Chen,et al.  Heat shock response inhibits NF-kappaB activation and cytokine production in murine Kupffer cells. , 2005, The Journal of surgical research.

[30]  L. Yu,et al.  SGLT‐1‐mediated glucose uptake protects intestinal epithelial cells against LPS‐induced apoptosis and barrier defects: a novel cellular rescue mechanism? , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[31]  V. Sekar,et al.  Administration of yeast glucan enhances survival and some non-specific and specific immune parameters in carp (Cyprinus carpio) infected with Aeromonas hydrophila. , 2005, Fish & shellfish immunology.

[32]  H. Hirasawa,et al.  Sequential measurement of IL-6 blood levels in patients with systemic inflammatory response syndrome (SIRS)/sepsis. , 2005, Cytokine.

[33]  Djillali Annane,et al.  Septic shock , 2005, The Lancet.

[34]  H. Wong,et al.  Temporal and Mechanistic Effects of Heat Shock on LPS-Mediated Degradation of IκBα in Macrophages , 2002, Inflammation.

[35]  J. Lim,et al.  Kinase-Activator Protein-1 Pathway in Raw Mitochondrial Reactive Oxygen Species-p38 Metalloproteinase-9 Expression via a Lipopolysaccharide Induces Matrix , 2004 .

[36]  H. Wong,et al.  Temporal and mechanistic effects of heat shock on LPS-mediated degradation of IkappaBalpha in macrophages. , 2002, Inflammation.

[37]  G. Clermont,et al.  Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care , 2001, Critical care medicine.

[38]  Paterson Rl,et al.  Sepsis and the systemic inflammatory response syndrome. , 2000, Journal of the Royal College of Surgeons of Edinburgh.

[39]  N. Webster,et al.  Sepsis and the systemic inflammatory response syndrome. , 2000, Journal of the Royal College of Surgeons of Edinburgh.

[40]  R. Andriantsitohaina,et al.  Overproduction of nitric oxide in pathophysiology of blood vessels. , 1998, Biochemistry. Biokhimiia.

[41]  M. Sporn,et al.  Novel triterpenoids suppress inducible nitric oxide synthase (iNOS) and inducible cyclooxygenase (COX-2) in mouse macrophages. , 1998, Cancer research.

[42]  P. Ghezzi,et al.  Effect of N-acetyl-L-cysteine on sepsis in mice. , 1995, European journal of pharmacology.

[43]  W. Knaus,et al.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. , 1992, Chest.